Pan-Cancer (N=930) | HB-Cancer (N=1151) | Pan-disease (N=4409) | HB-disease (N=21002) | Control (N=5895) | Total (N=33387) | p value | |
---|---|---|---|---|---|---|---|
Gender | < 0.0011 | ||||||
   Female | 439 (47.2%) | 430 (37.4%) | 2043 (46.3%) | 11186 (53.3%) | 1681 (28.5%) | 15779 (47.3%) | |
   Male | 491 (52.8%) | 721 (62.6%) | 2366 (53.7%) | 9816 (46.7%) | 4214 (71.5%) | 17608 (52.7%) | |
Ethnicity | < 0.0011 | ||||||
   White | 519 (66.6%) | 549 (53.7%) | 2370 (57.6%) | 10396 (51.5%) | 3280 (57.7%) | 17114 (53.9%) | |
   South Asian | 79 (10.1%) | 230 (22.5%) | 874 (21.2%) | 5207 (25.8%) | 942 (16.6%) | 7332 (23.1%) | |
   Black | 98 (12.6%) | 121 (11.8%) | 408 (9.9%) | 2046 (10.1%) | 806 (14.2%) | 3479 (10.9%) | |
   Far/South-east Asian | 4 (0.5%) | 24 (2.3%) | 19 (0.5%) | 234 (1.2%) | 31 (0.5%) | 312 (1.0%) | |
   Arab/North African | 0 (0.0%) | 0 (0.0%) | 1 (0.0%) | 15 (0.1%) | 5 (0.1%) | 21 (0.1%) | |
   Asian (Other) | 17 (2.2%) | 46 (4.5%) | 178 (4.3%) | 970 (4.8%) | 234 (4.1%) | 1445 (4.5%) | |
   Mixed | 9 (1.2%) | 8 (0.8%) | 49 (1.2%) | 241 (1.2%) | 78 (1.4%) | 385 (1.2%) | |
   Other | 53 (6.8%) | 45 (4.4%) | 217 (5.3%) | 1065 (5.3%) | 306 (5.4%) | 1686 (5.3%) | |
Diagnosis age (years) | < 0.0012 | ||||||
   Mean (SD) | 66.91 (12.72) | 65.24 (13.22) | 52.90 (18.51) | 53.64 (17.67) | 54.77 (17.59) | 54.51 (17.77) | |
   Median | 67.21 | 66.06 | 51.28 | 52.42 | 54.09 | 53.62 | |
   Q1,Q3 | 58.88, 76.07 | 56.79, 75.15 | 38.36, 67.20 | 39.90, 66.40 | 41.02, 68.00 | 40.66, 67.85 | |
Diagnosis age group | < 0.0011 | ||||||
   18-40 | 27 (2.9%) | 54 (4.7%) | 1318 (29.9%) | 5663 (27.0%) | 1470 (24.9%) | 8532 (25.6%) | |
   41-50 | 66 (7.1%) | 100 (8.7%) | 862 (19.6%) | 4149 (19.8%) | 1097 (18.6%) | 6274 (18.8%) | |
   51-60 | 189 (20.3%) | 266 (23.1%) | 773 (17.5%) | 4186 (19.9%) | 1163 (19.7%) | 6577 (19.7%) | |
   61-70 | 290 (31.2%) | 325 (28.2%) | 574 (13.0%) | 3022 (14.4%) | 961 (16.3%) | 5172 (15.5%) | |
   71-80 | 234 (25.2%) | 273 (23.7%) | 519 (11.8%) | 2311 (11.0%) | 733 (12.4%) | 4070 (12.2%) | |
   >80 | 124 (13.3%) | 133 (11.6%) | 363 (8.2%) | 1671 (8.0%) | 471 (8.0%) | 2762 (8.3%) | |
Mortality | < 0.0011 | ||||||
   Deceased | 754 (81.1%) | 795 (69.1%) | 840 (19.1%) | 3634 (17.3%) | 614 (10.4%) | 6637 (19.9%) | |
   Survived | 176 (18.9%) | 356 (30.9%) | 3569 (80.9%) | 17368 (82.7%) | 5281 (89.6%) | 26750 (80.1%) | |
Survival (months) | < 0.0012 | ||||||
   Mean (SD) | 15.88 (24.91) | 22.37 (29.54) | 49.69 (64.39) | 58.03 (77.33) | 57.50 (71.17) | 54.43 (73.08) | |
   Median | 8.05 | 12.47 | 28.93 | 34.87 | 36.57 | 32.20 | |
   Q1,Q3 | 2.58, 18.18 | 3.52, 29.40 | 9.60, 66.17 | 12.50, 73.46 | 14.57, 71.95 | 11.07, 69.57 |
HB-disease (N=21002) | Control (N=5895) | Total (N=26897) | p value | |
---|---|---|---|---|
Gender | < 0.0011 | |||
   Female | 11186 (53.3%) | 1681 (28.5%) | 12867 (47.8%) | |
   Male | 9816 (46.7%) | 4214 (71.5%) | 14030 (52.2%) | |
Ethnicity | < 0.0011 | |||
   White | 10396 (51.5%) | 3280 (57.7%) | 13676 (52.9%) | |
   South Asian | 5207 (25.8%) | 942 (16.6%) | 6149 (23.8%) | |
   Black | 2046 (10.1%) | 806 (14.2%) | 2852 (11.0%) | |
   Far/South-east Asian | 234 (1.2%) | 31 (0.5%) | 265 (1.0%) | |
   Arab/North African | 15 (0.1%) | 5 (0.1%) | 20 (0.1%) | |
   Asian (Other) | 970 (4.8%) | 234 (4.1%) | 1204 (4.7%) | |
   Mixed | 241 (1.2%) | 78 (1.4%) | 319 (1.2%) | |
   Other | 1065 (5.3%) | 306 (5.4%) | 1371 (5.3%) | |
Diagnosis age (years) | < 0.0012 | |||
   Mean (SD) | 53.64 (17.67) | 54.77 (17.59) | 53.88 (17.66) | |
   Median | 52.42 | 54.09 | 52.75 | |
   Q1,Q3 | 39.90, 66.40 | 41.02, 68.00 | 40.13, 66.79 | |
Diagnosis age group | < 0.0011 | |||
   18-40 | 5663 (27.0%) | 1470 (24.9%) | 7133 (26.5%) | |
   41-50 | 4149 (19.8%) | 1097 (18.6%) | 5246 (19.5%) | |
   51-60 | 4186 (19.9%) | 1163 (19.7%) | 5349 (19.9%) | |
   61-70 | 3022 (14.4%) | 961 (16.3%) | 3983 (14.8%) | |
   71-80 | 2311 (11.0%) | 733 (12.4%) | 3044 (11.3%) | |
   >80 | 1671 (8.0%) | 471 (8.0%) | 2142 (8.0%) | |
Mortality | < 0.0011 | |||
   Deceased | 3634 (17.3%) | 614 (10.4%) | 4248 (15.8%) | |
   Survived | 17368 (82.7%) | 5281 (89.6%) | 22649 (84.2%) | |
Survival (months) | 0.0382 | |||
   Mean (SD) | 58.03 (77.33) | 57.50 (71.17) | 57.91 (76.02) | |
   Median | 34.87 | 36.57 | 35.27 | |
   Q1,Q3 | 12.50, 73.46 | 14.57, 71.95 | 13.00, 73.20 |
HB-disease (N=21002) | Control (N=5895) | Total (N=26897) | p value | |
---|---|---|---|---|
Comorbidity | < 0.0011 | |||
   Mean (SD) | 2.40 (1.98) | 1.92 (1.87) | 2.30 (1.97) | |
   Median | 2.00 | 1.00 | 2.00 | |
   Q1,Q3 | 1.00, 4.00 | 0.00, 3.00 | 1.00, 4.00 | |
Diabetes | 5595 (26.6%) | 1010 (17.1%) | 6605 (24.6%) | < 0.0012 |
Hypertension | 10249 (48.8%) | 2545 (43.2%) | 12794 (47.6%) | < 0.0012 |
Cholesterol | 8766 (41.7%) | 2226 (37.8%) | 10992 (40.9%) | < 0.0012 |
Asthma | 3351 (16.0%) | 874 (14.8%) | 4225 (15.7%) | 0.0352 |
COPD | 1324 (6.3%) | 306 (5.2%) | 1630 (6.1%) | 0.0022 |
TB | 311 (1.5%) | 67 (1.1%) | 378 (1.4%) | 0.0472 |
Kidney | 3705 (17.6%) | 821 (13.9%) | 4526 (16.8%) | < 0.0012 |
Cardiovascular | 5631 (26.8%) | 1362 (23.1%) | 6993 (26.0%) | < 0.0012 |
Upper GI | 7192 (34.2%) | 1287 (21.8%) | 8479 (31.5%) | < 0.0012 |
Lower GI | 2667 (12.7%) | 682 (11.6%) | 3349 (12.5%) | 0.0202 |
F/H: Cancer | 4309 (20.5%) | 1141 (19.4%) | 5450 (20.3%) | 0.0502 |
F/H: Digestive | 590 (2.8%) | 120 (2.0%) | 710 (2.6%) | 0.0012 |
F/H: Diabetes | 6356 (30.3%) | 1484 (25.2%) | 7840 (29.1%) | < 0.0012 |
HB-disease (N=21002) | Control (N=5895) | Total (N=26897) | p value | |
---|---|---|---|---|
Smoker | < 0.0011 | |||
   Not available | 2288 (10.9%) | 481 (8.2%) | 2769 (10.3%) | |
   Never | 8547 (40.7%) | 2278 (38.6%) | 10825 (40.2%) | |
   Past | 5240 (25.0%) | 1767 (30.0%) | 7007 (26.1%) | |
   Current | 4927 (23.5%) | 1369 (23.2%) | 6296 (23.4%) | |
Drinker | < 0.0011 | |||
   Not available | 5201 (24.8%) | 1228 (20.8%) | 6429 (23.9%) | |
   Never | 4869 (23.2%) | 1340 (22.7%) | 6209 (23.1%) | |
   Past | 1023 (4.9%) | 291 (4.9%) | 1314 (4.9%) | |
   Current | 9909 (47.2%) | 3036 (51.5%) | 12945 (48.1%) | |
Substance user | < 0.0011 | |||
   Not available | 12167 (57.9%) | 2739 (46.5%) | 14906 (55.4%) | |
   Never | 4317 (20.6%) | 2117 (35.9%) | 6434 (23.9%) | |
   Past | 98 (0.5%) | 37 (0.6%) | 135 (0.5%) | |
   Current | 4420 (21.0%) | 1002 (17.0%) | 5422 (20.2%) | |
Obese | < 0.0011 | |||
   Not available | 2459 (11.7%) | 540 (9.2%) | 2999 (11.1%) | |
   Never | 3815 (18.2%) | 1269 (21.5%) | 5084 (18.9%) | |
   Past | 7881 (37.5%) | 2539 (43.1%) | 10420 (38.7%) | |
   Current | 6847 (32.6%) | 1547 (26.2%) | 8394 (31.2%) |
HB-disease (N=17725) | Control (N=5074) | Total (N=22799) | p value | |
---|---|---|---|---|
Gender | < 0.0011 | |||
   Female | 9680 (54.6%) | 1457 (28.7%) | 11137 (48.8%) | |
   Male | 8045 (45.4%) | 3617 (71.3%) | 11662 (51.2%) | |
Ethnicity | < 0.0011 | |||
   White | 8541 (48.4%) | 2788 (55.5%) | 11329 (50.0%) | |
   South Asian | 5043 (28.6%) | 898 (17.9%) | 5941 (26.2%) | |
   Black | 1879 (10.6%) | 755 (15.0%) | 2634 (11.6%) | |
   Far/South-east Asian | 205 (1.2%) | 29 (0.6%) | 234 (1.0%) | |
   Arab/North African | 15 (0.1%) | 5 (0.1%) | 20 (0.1%) | |
   Asian (Other) | 879 (5.0%) | 219 (4.4%) | 1098 (4.8%) | |
   Mixed | 219 (1.2%) | 71 (1.4%) | 290 (1.3%) | |
   Other | 865 (4.9%) | 260 (5.2%) | 1125 (5.0%) | |
Diagnosis age (years) | < 0.0012 | |||
   Mean (SD) | 52.84 (17.41) | 53.84 (17.18) | 53.07 (17.37) | |
   Median | 51.53 | 53.14 | 51.83 | |
   Q1,Q3 | 39.22, 65.10 | 40.29, 66.68 | 39.49, 65.48 | |
Diagnosis age group | < 0.0011 | |||
   18-40 | 4997 (28.2%) | 1326 (26.1%) | 6323 (27.7%) | |
   41-50 | 3632 (20.5%) | 991 (19.5%) | 4623 (20.3%) | |
   51-60 | 3528 (19.9%) | 1010 (19.9%) | 4538 (19.9%) | |
   61-70 | 2466 (13.9%) | 820 (16.2%) | 3286 (14.4%) | |
   71-80 | 1834 (10.3%) | 581 (11.5%) | 2415 (10.6%) | |
   >80 | 1268 (7.2%) | 346 (6.8%) | 1614 (7.1%) | |
Mortality | < 0.0011 | |||
   Deceased | 2788 (15.7%) | 483 (9.5%) | 3271 (14.3%) | |
   Survived | 14937 (84.3%) | 4591 (90.5%) | 19528 (85.7%) | |
Survival (months) | 0.3712 | |||
   Mean (SD) | 65.78 (81.22) | 64.21 (73.97) | 65.43 (79.67) | |
   Median | 42.17 | 42.40 | 42.20 | |
   Q1,Q3 | 18.23, 82.13 | 19.81, 78.11 | 18.57, 81.13 |
HB-disease (N=17725) | Control (N=5074) | Total (N=22799) | p value | |
---|---|---|---|---|
Comorbidity | < 0.0011 | |||
   Mean (SD) | 2.55 (2.02) | 1.99 (1.92) | 2.42 (2.01) | |
   Median | 2.00 | 2.00 | 2.00 | |
   Q1,Q3 | 1.00, 4.00 | 0.00, 3.00 | 1.00, 4.00 | |
Diabetes | 4978 (28.1%) | 884 (17.4%) | 5862 (25.7%) | < 0.0012 |
Hypertension | 8933 (50.4%) | 2183 (43.0%) | 11116 (48.8%) | < 0.0012 |
Cholesterol | 8132 (45.9%) | 2065 (40.7%) | 10197 (44.7%) | < 0.0012 |
Asthma | 3079 (17.4%) | 783 (15.4%) | 3862 (16.9%) | 0.0012 |
COPD | 1077 (6.1%) | 237 (4.7%) | 1314 (5.8%) | < 0.0012 |
TB | 306 (1.7%) | 66 (1.3%) | 372 (1.6%) | 0.0352 |
Kidney | 3082 (17.4%) | 679 (13.4%) | 3761 (16.5%) | < 0.0012 |
Cardiovascular | 4676 (26.4%) | 1131 (22.3%) | 5807 (25.5%) | < 0.0012 |
Upper GI | 6897 (38.9%) | 1266 (25.0%) | 8163 (35.8%) | < 0.0012 |
Lower GI | 2627 (14.8%) | 653 (12.9%) | 3280 (14.4%) | < 0.0012 |
F/H: Cancer | 4309 (24.3%) | 1141 (22.5%) | 5450 (23.9%) | 0.0072 |
F/H: Digestive | 559 (3.2%) | 116 (2.3%) | 675 (3.0%) | 0.0012 |
F/H: Diabetes | 6340 (35.8%) | 1482 (29.2%) | 7822 (34.3%) | < 0.0012 |
HB-disease (N=17725) | Control (N=5074) | Total (N=22799) | p value | |
---|---|---|---|---|
Smoker | < 0.0011 | |||
   Not available | 61 (0.3%) | 16 (0.3%) | 77 (0.3%) | |
   Never | 8180 (46.1%) | 2130 (42.0%) | 10310 (45.2%) | |
   Past | 5078 (28.6%) | 1685 (33.2%) | 6763 (29.7%) | |
   Current | 4406 (24.9%) | 1243 (24.5%) | 5649 (24.8%) | |
Drinker | < 0.0011 | |||
   Not available | 2939 (16.6%) | 674 (13.3%) | 3613 (15.8%) | |
   Never | 4566 (25.8%) | 1204 (23.7%) | 5770 (25.3%) | |
   Past | 1016 (5.7%) | 288 (5.7%) | 1304 (5.7%) | |
   Current | 9204 (51.9%) | 2908 (57.3%) | 12112 (53.1%) | |
Substance user | < 0.0011 | |||
   Not available | 9854 (55.6%) | 2237 (44.1%) | 12091 (53.0%) | |
   Never | 3999 (22.6%) | 1965 (38.7%) | 5964 (26.2%) | |
   Past | 92 (0.5%) | 33 (0.7%) | 125 (0.5%) | |
   Current | 3780 (21.3%) | 839 (16.5%) | 4619 (20.3%) | |
Obese | < 0.0011 | |||
   Not available | 373 (2.1%) | 101 (2.0%) | 474 (2.1%) | |
   Never | 3524 (19.9%) | 1174 (23.1%) | 4698 (20.6%) | |
   Past | 7539 (42.5%) | 2400 (47.3%) | 9939 (43.6%) | |
   Current | 6289 (35.5%) | 1399 (27.6%) | 7688 (33.7%) |